As a global enterprise with a diversified business portfolio, the Bayer Group enjoys many opportunities and is also exposed to numerous risks. The anticipated development opportunities are materially unchanged from those outlined in the Bayer Annual Report 2009.
A risk management system is in place. Apart from financial risks there are also business-specific selling market, procurement market, product development, patent, production, environmental and regulatory risks. Legal risks exist particularly in the areas of product liability, competition and antitrust law, patent disputes, tax assessments and environmental matters. Significant changes that have occurred in respect of the legal risks since publication of the Bayer Annual Report 2009 are described in the Notes to the Condensed Consolidated Interim Financial Statements of the Bayer Group under
“Legal Risks.” Information on the Bayer Group’s risk situation is provided in the Bayer Annual Report 2009 under
“Opportunity and Risk Report” and
“Legal Risks.” The Bayer Annual Report 2009 can be downloaded free of charge at
http://www.bayer.com/en/annual-reports.aspx.
At present, no potential risks have been identified that either individually or in combination could endanger the continued existence of the Bayer Group.